DaVita HealthCare Partners is a leading provider of kidney care services in the United States, offering a comprehensive range of dialysis and related healthcare services for patients with chronic kidney failure and end-stage renal disease
The company operates a vast network of outpatient dialysis centers and provides integrated care management and support for patients through various healthcare services, including nutritional counseling, social services, and patient education. DaVita is committed to improving patient outcomes and enhancing the quality of life for those affected by kidney disease while working closely with healthcare providers, payers, and communities to address the evolving challenges of kidney care.
CHICAGO and DENVER, Feb. 27, 2025 (GLOBE NEWSWIRE) -- YMCA of the USA (Y-USA), the national resource office for the 2,600+ YMCAs across the country, is excited to expand its collaboration with DaVita, a leading provider of comprehensive kidney care, to advance chronic disease education and prevention for individuals and their families who are either managing or at risk for chronic kidney disease (CKD). CKD disproportionately affects individuals with risk factors such as hypertension and diabetes.
Outpatient physical therapy provider U.S. Physical Therapy (NYSEUSPH) will be announcing earnings results tomorrow after market close. Here’s what investors should know.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.
Warren Buffett's investment firm, Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B), has offloaded a 2% stake in dialysis service provider, DaVita Inc. (NYSEDVA). The transaction, executed between February 14 and 19, is valued at around $116 million.
Shares of dialysis provider DaVita Inc. (NYSEDVA)
fell 14% in the morning session after the company reported weak fourth-quarter results: DaVita narrowly exceeded analysts' revenue expectations but fell short on full-year EPS guidance. A key challenge remains patient volume, as center closures could continue to pressure growth. Overall, this quarter could have been better.
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Dialysis provider DaVita Inc. (NYSEDVA) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.7% year on year to $3.29 billion. Its non-GAAP profit of $2.24 per share was 4.3% above analysts’ consensus estimates.
The shares of DaVita Inc.(NYSEDVA) plunged 10.2% in pre-market hours trading on Friday after Berkshire Hathaway trimmed its stake in the company. The dialysis provider also issued a weak outlook for 2025 as it announced its results after the market close on Thursday.
